Key stats
About Columbia Research Enhanced Value ETF
Expense ratio
0.19%
Home page
Inception date
Sep 25, 2019
REVS aims to beat the Russell 1000 Value Index by subtraction. The fund tracks an index that starts with the Russell 1000 Value, then removes stocks that dont pass its quality, value and momentum screens on a sector by sector basis. (Fund docs offer little additional detail on the factor inputs.) Stocks that make the cut are market cap weighted, and sector weights are aligned with those of the Russell 1000 Value. In all, the fund aims to beat its bogey solely by stock de-selection while avoiding sector bets. A footnote: biotech stocks (if any) are not screened and therefore are proportionally included.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Finance
Health Technology
Stocks97.94%
Finance25.23%
Health Technology10.82%
Electronic Technology8.07%
Consumer Non-Durables6.57%
Producer Manufacturing6.53%
Energy Minerals6.16%
Utilities4.64%
Technology Services4.57%
Transportation4.25%
Consumer Services4.13%
Retail Trade3.96%
Process Industries3.13%
Health Services2.26%
Consumer Durables2.22%
Non-Energy Minerals1.95%
Distribution Services1.45%
Communications1.12%
Industrial Services0.50%
Commercial Services0.38%
Bonds, Cash & Other2.06%
ETF1.13%
Cash0.93%
Miscellaneous0.00%
Stock breakdown by region
North America99.59%
Europe0.41%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history